Nafamostat mesilate treatment during open heart operation in immune thrombocytopenic purpura

Citation
K. Nakamura et al., Nafamostat mesilate treatment during open heart operation in immune thrombocytopenic purpura, ANN THORAC, 70(6), 2000, pp. 2161-2163
Citations number
9
Categorie Soggetti
Cardiovascular & Respiratory Systems","Medical Research Diagnosis & Treatment
Journal title
ANNALS OF THORACIC SURGERY
ISSN journal
00034975 → ACNP
Volume
70
Issue
6
Year of publication
2000
Pages
2161 - 2163
Database
ISI
SICI code
0003-4975(200012)70:6<2161:NMTDOH>2.0.ZU;2-9
Abstract
A 58-year old woman with idiopathic thrombocytopenic purpura underwent mitr al and aortic valve replacements and tricuspid annuloplasty. Preoperative t herapeutic interventions including prednisone and immunoglobulin were succe ssful in elevating the platelet count to 93,000/mm(2). Furthermore, we used nafamostat mesilate for coagulopathy prophylaxis during cardiopulmonary by pass. Postoperative bleeding was average and clinical course was uneventful . The perioperative management for patients with idiopathic thrombocytopeni c purpura requiring cardiac operation is reviewed. (Ann Thorac Surg 2000;70 :2161-3) (C) 2000 by The Society of Thoracic Surgeons.